![David Augustsson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Augustsson
Investor Relations Contact chez
ONCOPEPTIDES AB
Fortune : 4 540 $ au 31/05/2026
Profil
David Augustsson currently works at Oncopeptides AB, as Director-Investor Relations & Communications from 2023.
Mr. Augustsson received his graduate degree from the University of Uppsala and graduate degree from Vienna University of Economics & Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ONCOPEPTIDES AB 0,01 % | 26/08/2025 | 23 161 ( 0,01 % ) | 4 540 $ | 31/05/2026 |
Postes actifs de David Augustsson
| Sociétés | Poste | Début |
|---|---|---|
| ONCOPEPTIDES AB | Investor Relations Contact | 01/01/2023 |
Formation de David Augustsson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Vienna University of Economics & Business
 Vienna University of Economics & Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncopeptides AB
 Oncopeptides AB Pharmaceuticals: MajorHealth Technology Develops chemotherapeutic pharmaceuticals of compounds for cancer treatment | Health Technology |
Choisissez Zonebourse 
